Immunogenicity and some safety features of a VEGF-based cancer therapeutic vaccine in rats, rabbits and non-human primates. [electronic resource]
Producer: 20100622Description: 3453-61 p. digitalISSN:- 1873-2518
- Adjuvants, Immunologic -- administration & dosage
- Animals
- Antibodies, Neoplasm -- blood
- Bacterial Outer Membrane Proteins -- administration & dosage
- Cancer Vaccines -- adverse effects
- Cercopithecinae
- Female
- Humans
- Immunization, Secondary
- Immunoglobulin G -- blood
- Immunotherapy, Active -- methods
- Liposomes -- administration & dosage
- Mice
- Neisseria meningitidis -- chemistry
- Neoplasms -- therapy
- Oleic Acids -- administration & dosage
- Rabbits
- Rats
- Rats, Wistar
- Recombinant Proteins -- genetics
- T-Lymphocytes -- immunology
- Vascular Endothelial Growth Factor A -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.